[go: up one dir, main page]

ITMI932412A1 - Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce - Google Patents

Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce

Info

Publication number
ITMI932412A1
ITMI932412A1 IT002412A ITMI932412A ITMI932412A1 IT MI932412 A1 ITMI932412 A1 IT MI932412A1 IT 002412 A IT002412 A IT 002412A IT MI932412 A ITMI932412 A IT MI932412A IT MI932412 A1 ITMI932412 A1 IT MI932412A1
Authority
IT
Italy
Prior art keywords
bloccanti
alfa
treatment
early ejaculation
ejaculation
Prior art date
Application number
IT002412A
Other languages
English (en)
Inventor
Giorgio Cavallini
Original Assignee
Giorgio Cavallini
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giorgio Cavallini filed Critical Giorgio Cavallini
Priority to IT93MI002412A priority Critical patent/IT1264965B1/it
Publication of ITMI932412A0 publication Critical patent/ITMI932412A0/it
Priority to EP94931582A priority patent/EP0728000A1/en
Priority to US08/624,603 priority patent/US5707999A/en
Priority to PCT/EP1994/003661 priority patent/WO1995013072A1/en
Priority to JP7513583A priority patent/JPH09504798A/ja
Publication of ITMI932412A1 publication Critical patent/ITMI932412A1/it
Application granted granted Critical
Publication of IT1264965B1 publication Critical patent/IT1264965B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT93MI002412A 1993-11-12 1993-11-12 Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce IT1264965B1 (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IT93MI002412A IT1264965B1 (it) 1993-11-12 1993-11-12 Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce
EP94931582A EP0728000A1 (en) 1993-11-12 1994-11-08 The use of alfuzosin or terazosin in the treatment of premature ejaculation
US08/624,603 US5707999A (en) 1993-11-12 1994-11-08 Use of alfuzosin or terazosin in the treatment of premature ejaculation
PCT/EP1994/003661 WO1995013072A1 (en) 1993-11-12 1994-11-08 The use of alfuzosin or terazosin in the treatment of premature ejaculation
JP7513583A JPH09504798A (ja) 1993-11-12 1994-11-08 早発性射精の治療におけるアルフゾシンまたはテラゾシンの使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT93MI002412A IT1264965B1 (it) 1993-11-12 1993-11-12 Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce

Publications (3)

Publication Number Publication Date
ITMI932412A0 ITMI932412A0 (it) 1993-11-12
ITMI932412A1 true ITMI932412A1 (it) 1995-05-12
IT1264965B1 IT1264965B1 (it) 1996-10-17

Family

ID=11367195

Family Applications (1)

Application Number Title Priority Date Filing Date
IT93MI002412A IT1264965B1 (it) 1993-11-12 1993-11-12 Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce

Country Status (5)

Country Link
US (1) US5707999A (it)
EP (1) EP0728000A1 (it)
JP (1) JPH09504798A (it)
IT (1) IT1264965B1 (it)
WO (1) WO1995013072A1 (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6228864B1 (en) 1997-10-28 2001-05-08 Vivus, Inc. Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
US6403597B1 (en) 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
US6037360A (en) * 1997-10-28 2000-03-14 Vivus, Incorporated Administration of 5-HT3 receptor antagonists to treat premature ejaculation
US5922341A (en) * 1997-10-28 1999-07-13 Vivus, Incorporated Local administration of pharmacologically active agents to treat premature ejaculation
DK1225881T3 (da) 1999-09-03 2006-06-12 Apbi Holdings Llc Anvendelsen af dapoxetin, en hurtigt-virkende selektiv serotonin genoptagelseshæmmer, til behandling af seksuel dysfunktion
EP1227757A1 (en) 1999-11-11 2002-08-07 Medicare Management Consultancy Limited Apparatus and method to assist in the diagnosis of premature ejaculation
US6495154B1 (en) * 2000-11-21 2002-12-17 Vivus Inc. On demand administration of clomipramine and salts thereof to treat premature ejaculation
NZ528935A (en) 2001-03-16 2004-10-29 Dmi Biosciences Inc Method of delaying ejaculation
US8575169B2 (en) * 2001-10-29 2013-11-05 Versi Group, Llc Method of treating sexual dysfunctions with delta opioid receptor agonist compounds
EP1874315A2 (en) * 2005-04-14 2008-01-09 Mount Cook Biosciences, Inc. Compositions of novel opioid compounds and method of use thereof
US8604082B2 (en) * 2005-12-13 2013-12-10 Trinity Laboratories, Inc. Method to treat premature ejaculation in humans
US20080160081A1 (en) * 2006-12-11 2008-07-03 Mutual Pharmaceutical Company, Inc. Alfuzosin formulations, methods of making, and methods of use
US20100092556A1 (en) * 2006-12-11 2010-04-15 Kristin Arnold Alfuzosin formulations, methods of making, and methods of use
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399581A (en) * 1990-12-26 1995-03-21 Laragh; John H. Method and compositions for treatment of sexual impotence

Also Published As

Publication number Publication date
WO1995013072A1 (en) 1995-05-18
US5707999A (en) 1998-01-13
JPH09504798A (ja) 1997-05-13
IT1264965B1 (it) 1996-10-17
EP0728000A1 (en) 1996-08-28
ITMI932412A0 (it) 1993-11-12

Similar Documents

Publication Publication Date Title
BR9608758A (pt) Uso de ribavirina e interferom alfa para o tratamento de hepatite c
BR9102988A (pt) Kit de estences e painel de desenho
ITMI932412A1 (it) Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce
ITMI912509A0 (it) Uso della nimesulide nel trattamento della cataratta
ITMI931673A0 (it) Uso della benzidamina nel trattamento di stati patologici causati dal tnf
ITRM930154A0 (it) Uso di terbinafina per il trattamento terapeutico della pneumocistosi.
KR940000406U (ko) 휴대용 간이사우나
ITMI912430A1 (it) Uso di un composto anilino-pirimidinico ad attivita' fungicida nel trattamento della venturia
KR930026025U (ko) 지압구를 겸한 손전등
KR950010930U (ko) 쑥뜸구
ITMI941064A0 (it) Uso della s-benzoilossimetiltiamina nel trattamento del diabete
KR910008644U (ko) 지압기
KR930025062U (ko) 지압기
KR950005686U (ko) 지압용 돌기가 형성된 라이타
KR950000471U (ko) 전신 안마기
KR940022021U (ko) 안마기
KR950013358U (ko) 안마기
KR940024238U (ko) 자기 맛사지기
IT1302920B1 (it) Uso della propoli nel trattamento della vitiligine e della psoriasi.
KR910010852U (ko) 안마기
KR940022030U (ko) 마사지 기능을 갖는 뜸질기
KR950016724U (ko) 갯벌을 이용한 사우나탕
KR910000304U (ko) 맛사아지 겸용 지압구
KR950008174U (ko) 쑥뜸구
KR950013361U (ko) 쑥뜸구

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971127